Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study ...
Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...
Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...
Cassava Sciences Inc. has agreed to a $40 million settlement over SEC charges related to misleading data for simufilam. The ...
Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...
An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild ...
Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.
Walk for hope. Walk for a loved one. Walk for a cure. Late October, nearly a hundred participants across 19 teams in LaGrange ...
Microglia are the brain's resident immune cells. Their job is to patrol the brain's blood vessels looking for invading ...
The five big factors increasing the risk for cognitive decline, dementia or both: diabetes, midlife hypertension or high ...